Intermittent scanning continuous glucose monitoring is safe and useful in postsurgical glucose monitoring after pancreatoduodenectomy
Fagher et al.
The finding, in our words
Combining intermittently scanned continuous glucose monitoring with periodic point-of-care testing provided safe and effective glycaemic control in non-ICU surgical patients following pancreatoduodenectomy, yielding significantly lower glucose levels than standard point-of-care monitoring.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
Over-the-counter continuous glucose monitors demonstrated reasonable agreement with overall capillary blood glucose trends in individuals without diabetes, yielding an overall mean absolute relative difference of 12.9%. However, sensor accuracy decreased following carbohydrate consumption, suggesting caution is required when using these devices for diagnostic cut-offs or exact-value monitoring.
Prakash et al., Journal of diabetes science and technology (paywalled) · source ↗
In a cross-sectional analysis of 1,883 participants, continuous glucose monitoring metrics classified prediabetes with modest discrimination (AUC 0.645–0.677), approaching but not matching haemoglobin A1c and fasting plasma glucose. The high discordance between conventional markers, with only 9.5% meeting both criteria, suggests CGM serves best as a complementary tool when laboratory results are discordant.
Rákóczi et al., Diabetes research and clinical practice (paywalled) · source ↗
In adults with type 2 diabetes and end-stage kidney failure on haemodialysis, real-time continuous glucose monitoring improved time in glycaemic target range and reduced time above range compared with capillary blood glucose testing, while time below range remained minimal and unchanged. This suggests patient-centric glucose monitoring may benefit this high-risk population, though further studies are needed to confirm these benefits.
Real-time continuous glucose monitoring proved accurate and reliable in 35 children with diabetic ketoacidosis in a paediatric intensive care unit, with 95% of readings falling within clinically acceptable zones when compared with point-of-care capillary and serum glucose measurements. Acidosis did not impair accuracy, supporting CGM use in acute paediatric care.
Pott et al., Journal of diabetes science and technology (paywalled) · source ↗
Non-invasive and minimally invasive blood glucose monitoring techniques enable continuous tracking without pain, although traditional invasive methods retain superior accuracy relative to reference blood glucose measurements. Emerging wearable biosensors and alternative matrices such as interstitial fluid, saliva, and sweat offer promising solutions to enhance patient compliance and quality of life.
Ahmadian et al., Journal of medical engineering & technology (paywalled) · source ↗